Brazzell Romulus K

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
9
Insider Sells Sum
$144,156.55

Insider Activity of Brazzell Romulus K

According to the SEC Form 4 filings, Brazzell Romulus K, being in a position of

  1. SEE REMARKS at Kala Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 9108 shares for $49,164,
    over all time since 2021-06-28, has bought 0 shares, and sold 51176 shares for $144,157.

The largest sale of all time was on 2021-10-26 and amounted to 25514 shares of Kala Pharmaceuticals, Inc. for $45,925.

Biography of Brazzell Romulus K

No biography is available at this moment.

2024-06-26SaleKala Pharmaceuticals, Inc.
KALA
SEE REMARKS
5,489
0.2012%
$4.75$26,073+28.91%
2024-05-31SaleKala Pharmaceuticals, Inc.
KALA
SEE REMARKS
2,002
0.0644%
$6.09$12,192-11.46%
2024-01-04SaleKala Pharmaceuticals, Inc.
KALA
SEE REMARKS
1,617
0.0577%
$6.74$10,899-2.14%
2023-01-04SaleKala Pharmaceuticals, Inc.
KALA
SEE REMARKS
73
0.0024%
$28.53$2,083-66.29%
2022-10-26SaleKala Pharmaceuticals, Inc.
KALA
SEE REMARKS
261
0.0168%
$6.51$1,699+128.67%
2022-06-27SaleKala Pharmaceuticals, Inc.
KALA
SEE REMARKS
3,144
0.0043%
$0.37$1,163-16.76%
2022-01-04SaleKala Pharmaceuticals, Inc.
KALA
SEE REMARKS
7,008
0.0097%
$1.30$9,110-72.68%
2021-10-26SaleKala Pharmaceuticals, Inc.
KALA
CHIEF MEDICAL OFFICER
25,514
0.0392%
$1.80$45,925-61.94%
2021-06-28SaleKala Pharmaceuticals, Inc.
KALA
CHIEF MEDICAL OFFICER
6,068
0.0098%
$5.77$35,012-72.03%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.